Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what progress the Medical Research Council has made on delivering ME/CFS research improvements.
The Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI), has prioritised research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) for many years, investing over £4.65 million since 2020, and welcomes high quality applications in this area.
MRC is working with the Department for Health and Social Care (DHSC) and the National Institute for Health and Care Research (NIHR) to deliver on agreed actions from the ME/CFS Final Delivery Plan. This includes funding strategic initiatives to increase research capacity and hosting engagement events to bring together research funders, commercial and academic researchers and patient representatives. For example, in November DHSC, NIHR and UKRI, co-hosted a research showcase to discuss and explore the ongoing research in the fields of ME/CFS and long COVID. MRC continues to liaise with the ME/CFS research community to support future applicants.